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Macrophages are strongly adapted to their tissue of
residence. Yet, little is known about the cell-cell inter-
actions that imprint the tissue-specific identities of
macrophages in their respective niches. Using condi-
tional depletion of liver Kupffer cells, we traced the
developmental stages of monocytes differentiating
into Kupffer cells andmapped the cellular interactions
imprinting the Kupffer cell identity. Kupffer cell loss
induced tumor necrosis factor (TNF)- and interleukin-
1 (IL-1) receptor-dependent activation of stellate cells
andendothelial cells, resulting in the transient produc-
tion of chemokines and adhesion molecules orches-
trating monocyte engraftment. Engrafted circulating
monocytes transmigrated into the perisinusoidal
space and acquired the liver-associated transcription
factors inhibitor of DNA 3 (ID3) and liver X receptor-a
(LXR-a). Coordinated interactions with hepatocytes
induced ID3 expression, whereas endothelial cells
and stellate cells induced LXR-a via a synergistic
NOTCH-BMP pathway. This study shows that the
Kupffer cell niche is composed of stellate cells, hepa-
tocytes, and endothelial cells that together imprint the
liver-specific macrophage identity.638 Immunity 51, 638–654, October 15, 2019 ª 2019 The Authors. P
This is an open access article under the CC BY-NC-ND license (http://INTRODUCTION
Macrophages were first identified in the late 19th century by
Elie Metchnikoff because of their participation in host defense
through phagocytosis (Metchnikoff, 1892). It is now clear that
macrophages also perform unique tissue-specific functions
that are not related to host defense but essential for tissue ho-
meostasis, such as electrical conduction in the heart, synaptic
pruning in the brain, or alveolar surfactant clearance in the
lung (Hulsmans et al., 2017; Paolicelli et al., 2011; Trapnell
et al., 2003; van de Laar et al., 2016). These functions are
thought to be performed by tissue-specific gene modules
controlled by specific transcription factors imprinted by their
microenvironment (Lavin et al., 2014; Okabe and Medzhitov,
2016; T’Jonck et al., 2018). Little is known about the cell-
cell interactions underlying the tissue-specific imprinting of
macrophages.
We have recently shown that depletion of liver-resident
macrophages, known as Kupffer cells (KCs), induces their repo-
pulation by bone marrow (BM) monocytes yielding monocyte-
derived KCs that are genetically and functionally nearly identical
to their embryonic counterparts (Scott et al., 2016). Furthermore,
recent studies have highlighted the central role of the transcrip-
tion factors LXR-a and ID3 in the control of the KC-specific iden-
tity given that genetic deletion of Id3 or Nr1h3 (encoding LXR-a)
induces the loss of KC identity and compromises KC survival
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and molecular interactions imprinting the expression of LXR-a
and ID3 in KCs are unknown.
In this study, we utilized a KC-specific depletion model to
decipher the signals driving monocyte recruitment, engraftment,
and acquisition of the KC-associated transcription factors and
identify the differential contributions of stellate cells, endothelial
cells, and hepatocytes to the KC niche.
RESULTS
Depleted KCs Are Exclusively Replaced by Monocyte-
Derived KCs
Clec4F is a lectin specifically expressed by Kupffer cells (KCs)
(Scott et al., 2016). Using Clec4fDTR/+ mice, we had previously
shown that Ly6Chi monocytes can act as KC precursors (Scott
et al., 2016). We crossed thesemice toCcr2GFP/+ mice to tempo-
rarily fate-map the green fluorescent protein (GFP)-expressing
monocytes differentiating into monocyte-derived KCs (mo-
KCs) and evaluate their relative contribution to the mo-KC pool
(Satpathy et al., 2013; Serbina and Pamer, 2006). Diphtheria
toxin (DT) injection induced a rapid disappearance of KCs
without affecting liver capsule macrophages and a strong
recruitment of Ly6Chi monocytes in the liver (12 h DT) that grad-
ually lost Ly6C and acquired both F4/80 and Clec4F (Figures 1A
and S1A–S1C; Video S1). At day 2 after KC loss, F4/80+ mo-KCs
uniformly expressed GFP as highly as Ly6Chi monocytes, and
from day 3 the GFP was gradually decreased, consistent with
the downregulation of Ccr2 (Figures 1A, 2B, and S1C). We also
observed a rapid increase of the mo-KC population between
day 2 and day 6 after KC depletion (Figure 1C). Transcriptome
analysis of mo-KCs at day 3 comparedwith days 1 and 7 showed
that the top 30 of upregulated genes were related to cell cycle,
indicating that mo-KCs were undergoing proliferation (Fig-
ure 1D). We next evaluated their proliferation rate by measuring
5-Ethyl-20-deoxyuridine (EdU) incorporation and KI-67 staining.
Mo-KCs showed a proliferation phase with a peak 3 days after
depletion (Figures 1E, 1F, and S1C). This proliferation phase
was dependent on colony-stimulating factor 1 (CSF1) receptor
(CSF1R) signaling as injection of PLX3397 (an inhibitor of
CSF1R) blocked mo-KC proliferation (Figure 1G) (Yan
et al., 2017).
We further investigated the replenishment of the KC popula-
tion in mice lacking Ccr2, which have a reduced pool of circu-Figure 1. Replenishment of KC Pool by Ly6Chi Monocytes
(A and B) Expression of GFP, Ly6C, and F4/80 of monocytes (green gate), em-K
Ccr2GFP/+ mice or (B) Clec4fDTR/+-Ccr2GFP/GFP mice. Flow-cytometry plots are p
representative of 2–3 experiments.
(C) Proportion of Ly6Chi monocytes (green lines), em-KCs (black lines), and m
Clec4fDTR/+-Ccr2GFP/GFPmice (dashed lines) as a percentage of live CD45+ cells af
1,5d; 2d; 5d; 6d), and 8 mice (3d; 4d).
(D) Heatmap showing the top 30 of upregulated genes in mo-KCs 3 days compa
(E) Expression of Ki-67 and EdU incorporation by em-KCs and mo-KCs in (top) Cl
injection. Flow-cytometry plots are pre-gated as in (A). Data are representative o
(F) Percentage of EdU+ cells in indicated populations during the differentiation
Ccr2GFP/GFP (dash line). Pooled data are from 2–3 experiments; n = 5 (0,5d), 6 (PB
test. *p < 0.05, ***p < 0.001, ****p < 0.0001.
(G) Percentage of EdU+ mo-KCs 3 days after DT injection in liver of mice treated w
Mann-Whitney t test. ***p < 0.001.
Related to Figure S1.
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quently, 2 days after DT injection Ccr2/ mice had 4 times
less mo-KCs than their heterozygous counterparts (Figures
1A–1C). Note that the remaining mo-KCs were GFPhi confirming
that they were still exclusively derived from the few circulating
Ly6Chi monocytes (Figure 1B). Nonetheless, at day 6 these
mice showed a restored mo-KC population because of a more
intense and prolonged proliferation phase than their heterozy-
gous counterparts (Figures 1E and 1F).
Altogether, these results indicate that the replenishment of the
KC pool involves a transient recruitment of monocytes within
12 h after KC depletion, followed by their differentiation into
F4/80+mo-KCs within 48 h and their subsequent CSF1R-depen-
dent proliferation until the population reaches the steady-state
KC density by day 6 after depletion. This engraftment and prolif-
eration phase occurred over the whole liver parenchyma and
was not restricted to a particular hepatic zone (Figure S1C).
The diminished recruitment of monocytes observed in the
Ccr2/ mice does not lead to the recruitment of other precur-
sors but is compensated by increased proliferation of the en-
grafted monocytes.
Acquisition of the KC Identity Begins within Hours after
Liver Engraftment
To better understand the signals inducing the engraftment and
differentiation ofmonocytes into KCs, we first set out to precisely
define the time frame of these events. We performed a transcrip-
tome analysis on bone marrow (BM) monocytes and mo-KCs 1,
3, 7, 15, and 30 days after KC depletion. Monocytes engrafted
within 24 h already lost classical monocyte genes and upregu-
lated general macrophage genes (Figure 2B). We next investi-
gated the expression of KC-associated transcription factors,
defined through the comparison of KCs with multiple tissue-resi-
dent macrophages obtained from the Immgen Consortium
(Gautier et al., 2012; Heng et al., 2008). This revealed that KC-
associated transcription factors were already highly expressed
in monocytes 24 h after DT injection (Figure 2C). Expression of
the KC-core genes (Scott et al., 2018) rapidly increased in the
following days (Figure 2D). However, this differentiation process
could be influenced by the DTR model and might not reflect the
KC development occurring during the embryogenesis. Tran-
scriptome analysis comparison of developing embryonic-
derived liver macrophages and developing mo-KCs showedCs (black gate), and mo-KCs (red gate) after DT injection in (A) Clec4fDTR/+-
re-gated on live CD45+CD11b+Lyve-1SiglecFLy6G single cells. Data are
o-KCs (red lines) in the liver of Clec4fDTR/+-Ccr2GFP/+ mice (solid lines) or
ter DT injection. Pooled data are from 2–3 experiments; n = 5 (0,5d), 6 (PBS, 1d;
red with 1 and 7 days after DT injection.
ec4fDTR/+-Ccr2GFP/+ mice or (bottom) in Clec4fDTR/+-Ccr2GFP/GFP mice after DT
f 2–3 experiments.
kinetic of mo-KCs in Clec4fDTR/+-Ccr2GFP/+ mice (solid line) or Clec4fDTR/+-
S, 1d, 1,5d, 2d, 5d, 6d), and 8 mice (3d, 4d). Two-way ANOVA with Tukey post-
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similar acquisition kinetics of KC-associated transcription fac-
tors and KC-core genes during both embryogenesis and the
DT repopulation model (Figures 2A, 2C, and 2D).
We next sought to investigate the precise time of engraft-
ment of monocytes by intravital two-photon imaging. We
crossed Clec4fDTR/+-Ccr2GFP/+ mice with Clec4fCre/+-Ro-
sa26TdT/+ mice to simultaneously visualize GFPhi monocytes
and TdThi KCs in live imaging during KC depletion. At
steady-state, monocytes were circulating in blood sinusoids
with an average speed of 8 mm/min and a confinement index
of 0.61 (Figure 2E; Video S2). KC depletion induced a rapid
change of monocyte behavior with a decrease of both the
average speed and the confinement index (Figure 2; Video
S3). Twenty-four hours after KC loss, many monocytes were
arrested and had adopted an elongated shape with big pro-
cesses, resembling KC morphology (Figure 2E; Video S4).
Size increase was confirmed by confocal analysis (Figure 2F).
However, both two-photon and confocal microscopy showed
that a fraction of monocytes remained round and did not arrest
in the liver (Figures 2E and 2F). We data-mined our transcrip-
tome data of monocytes developing into KCs and searched
by genes coding for surface markers that would rapidly be
upregulated by mo-KCs. We found that both Itgax (coding
for CD11c) and major histocompatibility complex II (MHCII)-
related genes (Cd74, H2-DMa, H2-Aa, and H2-Ab1) were
expressed in monocytes recruited to the liver 24 h after DT
injection (Figure 2B). We therefore analyzed the expression of
CD11c and MHCII during mo-KC differentiation. At steady-
state, monocytes were CD11cMHCII whereas KCs were
CD11cloMHCIIhi (Figure 2G). Twenty-four hours after depletion,
a proportion of monocytes were CD11chiMHCIIhi whereas the
residual cells remained CD11cloMHCIIlo, confirming the
concomitant presence of two monocyte populations in the liver
at that time (Figure 2G). In accordance with the transcriptome
profile, MHCII remained stable over time on mo-KCs whereas
CD11c was gradually downregulated from day 3 onward to
reach the steady-state KC expression at 6 day (Figures 2A
and 2G). Confocal microscopy revealed that MHCIIhi mono-
cytes were corresponding to the elongated engrafted popula-
tion whereas MHCII monocytes were smaller circulating
monocytes with a round shape (Figure 2F). Furthermore,
qRT-PCR revealed that 24 h after depletion the engrafted
CD11chiMHCIIhi monocytes had upregulated KC-associatedFigure 2. Recruited Monocytes Engraft in the Liver and Acquire KC-Sp
(A) F4/80 and Clec4F expression during embryogenesis. Gates indicate the diffe
(B–D) Heatmap showing expression by the indicated cell populations of (B) mono
compared with other tissue-resident macrophages, and (D) KC-cores genes.
(E) Shown in the top row is an in vivo two-photon microscopy analysis of livers
sponding to Video S2) or with DT for 10 h (middle, corresponding to Video S3) or 2
automated tracking of GFP+monocytes in the liver during 1 h. On the bottom are th
of individual monocyte tracks of the above conditions. Pooled data from 2–3 exp
(F) On top is the maximal intensity projection (MIP) ofClec4fDTR/+-Ccr2GFP/+ mouse
24 h after DT injection. MHCII monocytes (asterisks) are round and MHCII+ m
quantification of monocyte size 24 h after PBS or DT injection (left graph) or, dep
data from 2 experiments, n = 4. Student’s t test. ****p < 0.0001. Dots represent i
(G) CD11c and MHC-II expression during mo-KC differentiation. Flow-cytometry
(Mono PBS; 0,5d and 1d) or F4/80+ cells (2d to em-KC PBS). Data are represent
(H) Relative expression of KC-associated transcription factor mRNA in indicated
ANOVA with Bonferroni post-test. **p < 0.01, ***p < 0.001, ****p < 0.0001.
642 Immunity 51, 638–654, October 15, 2019transcription factors, whereas CD11cMHCII monocytes
had not (Figure 2H).
Altogether, these results show that only a fraction of themono-
cytes recruited upon KC death will engraft in the liver and acquire
a CD11cHiMHCIIHi profile, display an elongated morphology and
express the KC-associated transcription factors.
Engrafted Monocytes and KCs Are in Close Interaction
withHepatic StellateCells andHepatocytes in theSpace
of Disse
The intravital microscopy revealed that the monocytes that had
arrested in one specific spot (Figure 3A, panels 1–6) began to
extend processes (Figure 3A, panels 7–11). Confocal micro-
scopy showed that these processes extended across the endo-
thelial vessel wall to reach the liver parenchyma (Figure 3B, panel
1). To identify the cellular target of these processes, we switched
to correlative light-electron microscopy (CLEM), a method that
allows to overlay fluorescence microscopy data with high reso-
lution electron microscopy (EM) (Figure 3B, panel 2; Figure S2A)
(Begemann andGalic, 2016). This revealed that engraftedmono-
cytes extended their processes through the endothelial blood
vessel to interact with a droplet-containing cell located in the
space of Disse (Figure 3B, panels 3 and 4; Video S5). On the ba-
sis of morphology, these cells were identified as hepatic stellate
cells (HSCs), pericytes known to store the hepatic retinol in cyto-
plasmic lipid droplet (Friedman, 2008). Desmin staining on liver
slices confirmed that elongated monocytes were strongly inter-
acting with HSCs through the extension of processes across
the endothelial cell wall (Figures 3C, 3D, and S2B).
We next investigated whether steady-state KCs were also in-
teracting with HSCs. Results showed a clear cell-cell interaction
between KCs and HSCs with part of KC body inside blood ves-
sels and part of their body inside the perisinusoidal space (Fig-
ures 3E and S2C). We also observed that KCs had multiple
processes extending to several blood vessels. Because of the
thinness of the perisinusoidal space, we decided to confirm
these findings by EM. CLEM was performed and 3D reconstruc-
tion confirmed a strong KC-HSC interaction taking place in the
space of Disse and demonstrated that KCs project their pro-
cesses into multiple sinusoidal blood vessels (Figure 3E;
Video S6).
Altogether, these results indicate that, contrary to the general
assumption that KCs reside exclusively in the sinusoidal bloodecific Identity within 24 h after KC Depletion
rent sorted populations used for the micro-array.
cyte- and macrophage-related genes, (C) KC-associated transcription factors
from Clec4fDTR/Cre-Ccr2GFP/+-Rosa26TdT/+ mice injected with PBS (left, corre-
4 h (right, corresponding to Video S4) is illustrated. Shown in the middle row is
e average speed and confinement index (maximumdisplacement/path length)
eriments. Scale bar, 20mm.
liver sections stained for GFP (monocytes), MHCII, and DAPI in PBS control or
onocytes (arrowheads) are elongated. Scale bar, 50mm. On the bottom is a
ending on their MHCII expression, 24 h after DT injection (right graph). Pooled
ndividual monocytes.
plots are pre-gated as in Figure 1A and further gated on Ly6ChiF4/80 cells
ative of 2–3 experiments.
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vessels, steady-state KCs and mo-KCs are always found with a
substantial part of their body in the space of Disse where they
strongly interact with HSCs. This puts KCs in continual cell-cell
contact with three main cell types as potential candidates for
the KC niche: liver sinusoidal endothelial cells (LSECs), HSCs,
and hepatocytes.
HSCs and LSECs Are Involved in Monocyte Recruitment
and Engraftment
We next sought to investigate which signals induce the rapid but
transient engraftment of monocytes within hours after KC loss.
Given that we had found that engrafted monocytes were closely
interacting with HSCs, LSECs and hepatocytes, we isolated
the 3 populations from PBS- and DT-injected mice 12 h and
36 h after injection and compared their transcriptomes (Figures
S3A–S3D). Principal component analysis revealed that HSCs
were strongly affected (515 differentially expressed [DE]
genes) 12 h after DT, LSECs were moderately affected (216 DE
genes), whereas hepatocytes were almost not affected (14 DE
genes) by KC depletion (Figures 4A and S4A). Ingenuity pathway
analysis performed on the DE genes indicated that HSCs
and LSECs displayed strong signatures for granulocyte and
agranulocyte adhesion and diapedesis (Figures 4B and S4B).
HSCs showed a strong upregulation of genes involved in mono-
cyte (Ccl2, Ccl7, Cxcl10, and Pf4) and neutrophil recruitment
(Cxcl1, Cxcl5, and Pf4). Genes coding for adhesion molecules
involved in the arrest and diapedesis of monocytes (Gerhardt
and Ley, 2015) were strongly upregulated by both HSCs
(Vcam1, Sele, and Icam1) and LSECs (Vcam1, Sele, Icam1,
and Selp) (Figure 4B). We next sought to validate this at the
protein level. Enzyme-linked immunosorbent assay (ELISA)
performed on serum from PBS- or DT-injected mice confirmed
a transient increase of CCL2 reaching a peak 8 h after DT injec-
tion (Figure 4C). Confocal microscopy detected a widely distrib-
uted pattern of CCL2 expression and identified HSCs as the
main CCL2-producing cells 8 h after DT (Figures 4D, arrows,
4E, and S3E). We occasionally found a few CCL2-expressing
LSECs (arrows) and monocytes (asterisks) (Figure 4D). We also
confirmed the temporal nature of CCL2 expression because
the chemokine was no longer detected 16 h after KC depletion
(Figure 4E). KC depletion also induced a transient increase of
Selectin-E and VCAM-1 on both HSCs and LSECs from 8 h toFigure 3. Recruited Monocytes and Steady-State Kupffer Cells Are in
(A) Still images of a time-series performed by intravital two-photon imaging of li
monocyte and the extension of a dendrite 10–16 h after DT injection.
(B) In 1 is the MIP of Clec4fDTR/+-Ccr2GFP/+ mouse liver sections, with CD31 (blue)
identification of the monocyte and to delimit the blood vessels. In 3 is 2D EM s
interacting with a droplet-rich cell (green) located in between hepatocytes (yello
periments. Scale bar, 5 mm.
(C) MIP ofClec4fDTR/+-Ccr2GFP/+ mouse liver sections stained for GFP (red), Desm
HSC-monocyte interactions outside of blood vessels (arrows). Data are represen
(D) 3D reconstruction of confocal microscopy fromClec4fDTR/+-Ccr2GFP/+mouse l
24 h after DT injection. Scale bar, 5mm.
(E) MIP of PBS control Clec4fDTR /+ mouse liver sections stained for Clec4F (red
experiments. Scale bar, 20mm.
(F) Shown in 1 is the MIP of Clec4fCre/+-Rosa26TdT/+ mouse liver sections with CD3
allowing identification of the KC and delimiting of the blood vessels. In 3 is a 2D E
vessels (blue) and located in between hepatocytes (yellow). In 4 is the 3D recons
Related to Figure S2.
644 Immunity 51, 638–654, October 15, 201916 h after DT injection, reaching a peak at 10 h after DT (Figures
4F and S3F).
Altogether, these results show that KC depletion transiently
activates HSCs and LSECs. Activated HSCs produce mono-
cyte-attracting chemokines, whereas both activated LSECs
and activated HSCs upregulate receptors involved in adhesion
and endothelial transmigration. Both chemokines and adhesion
molecules are expressed for a restricted time period that coin-
cides with the engraftment and transmigration of monocytes
into the space of Disse observed by microscopy. This transient
window probably explains why only a fraction of the recruited
monocytes were able to engraft in the liver and why proliferation
of thesemo-KCs was subsequently required to completely repo-
pulate the KC pool.
HSC and LSEC Activation Are Mediated by IL-1 and TNF
Released Mainly by Dying KCs
We next set out to identify the signals driving the activation of
HSCs and LSECs upon KC loss. To do so, we used NicheNet,
an algorithm that infers ligand-receptor interactions inducing
gene expression variations by combining transcriptome data of
interacting cells with existing knowledge on signaling and gene
regulatory networks (Browaeys and Saeys, 2019). We applied
NicheNet to predict which ligand-receptor interactions could
potentially induce the DE genes found in activated HSCs and
LSECs (Figure 5A). The top 5 predicted ligands were tumor ne-
crosis factor (TNF), interleukin-1a (IL-1a) and IL-1b, interferon
gamma (IFN-g), and the apolipoprotein E. HSCs strongly ex-
pressed all TNF receptors, IL-1 receptor 1, and IFN-g receptors,
whereas LSECs expressed Tnfrsf1a, Ltbr, IFN-g receptors, Ldlr,
and Il1r1 (Figure 5A). On the basis of predicted upstream ligand
activity and receptor expression, we hypothesized that TNF and/
or IL-1 were responsible for HSC and LSEC activation. We thus
blocked them by injecting a cocktail of anti-TNF antibodies and
Anakinra, a recombinant antagonist protein preventing the bind-
ing of both IL-1a and IL-1b to the IL-1 receptor (Cavalli and Dinar-
ello, 2018). Confocal imaging and flow-cytometry analysis
showed that CCL2 production by HSCs as well as Vascular
cell adhesion molecule-1 (VCAM-1) and Selectin E upregulation
by HSCs and LSECs were efficiently inhibited by the blocking
cocktail (Figures 5B, 5C, and S5A). Consequently, anti-TNF
and Anakinra treatment efficiently blocked the recruitment ofClose Contact with Hepatic Stellate Cells in the Space of Disse
ver from Clec4fDTR/Cre-Ccr2GFP/+-Rosa26TdT/+ mice showing engraftment of a
and GFP (red). In 2 is the overlay of confocal microscopy and EM, allowing the
lice showing the monocyte (red) passing through the endothelium (blue) and
w). Shown in 4, 3D reconstruction of the EM. Data are representative of 2 ex-
in (green), CD31 (blue), and DAPI (gray) 24 h after DT injection, showingmultiple
tative of 3 experiments. Scale bar, 10mm.
iver sections stained for GFP (red), Desmin (green), CD31 (blue), and DAPI (gray)
), Desmin (green), CD31 (blue), and DAPI (gray). Data are representative of 5
1 (blue) and TdTomato (red). In 2 is the overlay of confocal microscopy and EM
M slice showing the KC (red) interacting with an HSC (green) outside of blood
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monocytes to the liver, whereas injection of anti-TNF or Anakinra
alone resulted in a partial block (Figures 5D and 5E). As Ly6Chi
monocytes engrafting in the liver could be identified by their
CD11chiMHCIIhi expression, we evaluated the effect of anti-
TNF and Anakinra treatment on their presence and found a
significant reduction of CD11chiMHCIIhi monocytes in the liver
(Figures 5F and 5G). However, 6 days after KC loss, treated
mice displayed the same proportion of KCs as isotype-injected
or non-depleted mice (Figure S5B). We thus hypothesized that,
as for Ccr2/ mice (Figure 1F), the few engrafted monocytes
proliferated more to compensate for the initial number reduction.
EdU incorporation revealed that mo-KCs from treated mice
exhibited a stronger and prolonged proliferation phase as
compared with isotype-injected mice (Figure S5C).
We next sought to identify the cellular source of TNF and IL-1.
Genes coding for these cytokines were found to be expressed
by KCs and upregulated by mo-KCs along their differentiation
(Figure S5D). Depletion of KCs deficient for TNF showed a signif-
icant reduction in the number of engrafted CD11chiMHCIIhi
monocytes 24 h after DT injection (Figures 5H and 5I). The drop
in Clec4fCre/DTRTnffl/fl mice and anti-TNF-treatedmicewere com-
parable, suggesting that the dying KCs are the main source of
TNF inducing the recruitment of monocytes. We next performed
microscopy staining of IL-1a and IL-1b. At steady-state, IL-1a
was not detected, whereas IL-1b appeared to be expressed by
few platelets (asterisks; Figure S5E). Five hours after DT injection
both IL-1a and IL-1b were detected in KCs (arrowheads; Fig-
ure S5E). IL-1b was also strongly expressed by many platelets
and, consistent with our RNA sequencing (RNA-seq) data, IL-
1a was found to be upregulated by LSECs (Figures S4C and
S5E, asterisks).
Altogether, these results identify TNF and IL-1 as the main up-
stream signals leading to the temporary activation of HSCs and
LSECs required for the recruitment and engraftment of mono-
cytes in the KC niche. The KCs themselves appear to be one
of the main sources of TNF and IL-1.
Bone Morphogenetic Proteins, Notch Signaling, and
CSF1 Serve as Potential Upstream Signals of Monocyte
Differentiation
We next set out to identify the signals imprinting the KC identity
on the engrafted monocytes. NicheNet was used to predict theFigure 4. HSCs and LSECs Induce Monocyte Recruitment and Engraft
(A) Principal component analysis of HSCs, LSECs, and hepatocytes at steady st
(B) Heatmap of genes involved in granulocyte and agranulocyte adhesion and di
ingenuity pathway analysis.
(C) Analysis by ELISA of CCL2 concentration in the serum of mice after DT injectio
injectedmice (no differences observed). Pooled data are from 3 experiments. Con
n = 5 (0h); 11 (4h, 16h); 12 (12h); 15 (10h) and 16 mice (8h). Two-way ANOVA wit
(D) On the left is the MIP of Clec4fDTR/+-Ccr2GFP/+ mouse liver sections stained fo
after DT injection. CCL2 wasmainly co-localized with HSCs (arrows), although a s
Data are representative of 2 experiments. Scale bar, 20 mm.
(E) Quantification of CCL2+ cells at the indicated time points and normalized p
experiments; n = 4. Two-way ANOVA with Tukey post-test. ****p < 0.0001.
(F) Quantification of VCAM-1 and selectin E expression by HSCs, LSECs, and hepa
at steady state, data are represented as median fluorescence intensity (MFI) fold
individual experiment. Selectin Ewas represented as percentage of positive cells i
16h, 24h, 48h), 9 (12h), 15 (PBS) and 17 mice (8h). One-way ANOVA with Bonfer
Related to Figure S3 and S4.
646 Immunity 51, 638–654, October 15, 2019top five of the potential ligand-receptor pairs that could induce
the transcriptome changes occurring between BM monocytes
and mo-KCs 3 days after KC loss combined with the top 5
ligand-receptors pairs that can induce the expression of the
top 20 KC-associated transcription factors (Figure 2C). Potential
HSC-derived ligands included Csf1, a cytokine involved in
monocyte-to-macrophage differentiation as well as macro-
phage chemotaxis, survival, and proliferation. Other HSC-
derived ligands included five bone morphogenetic proteins
(BMPs): Bmp4, Gdf2 (coding for BMP9), Gdf6, Bmp5, and
Bmp10 (Figure 6A); BMP9 was the most highly expressed
BMP by the HSCs. The top 10 LSEC potential ligands included
BMPs (Bmp2, Bmp6, and Inhbb) and Notch-signaling pathways
ligands (Dll1 and Dll4) (Figure 6A); BMP2 was the most highly
expressed BMP by the LSECs. Finally, among the potential li-
gands of hepatocytes, one (Inhbc) belonged to the BMP family
(Figure 6A). A circle plot was designed to show the principal
target genes for the main predicted upstream signals and the
expression of the receptors for the main ligands and the target
genes of these ligand-receptor interactions were mapped on
monocytes differentiating into KCs (Figures 6B and 6C). This
underlined the important overlap between potential BMP-
induced and potential DLL-Notch-induced target genes.
Altogether, NicheNet highlighted the following signals as po-
tential upstream signals driving KC development: CSF1 from
HSCs, DLL-Notch from LSECs, and BMPs from both HSCs
and LSECs.
HSCs, LSECs, andHepatocytes Differentially Contribute
to KC Development
To better characterize the expression of CSF1 in the liver, we
performed confocal imaging on steady-state liver tissue 8 h
after depletion. In accordance with our transcriptomic data,
at steady-state HSCs were identified as the main CSF1-
expressing cells with only few CSF1-expressing LSECs, identi-
fying HSCs as the main source of CSF1 within the steady-
state KC niche (Figures 7A, S6A, and S6B). Nonetheless,
depletion of KCs induced a transient upregulation of CSF1 pro-
duction by both cell types, indicating that HSCs and LSECs
may play a role during monocyte differentiation and prolifera-
tion (Figures S6A, S6B, and S6C and 1E–1G). IL-34 is another
known ligand of CSF1R (Wang and Colonna, 2014). In contrastment in the Liver after Kupffer Depletion
ate, 12 h or 36 h after DT injection.
apedesis upregulated by HSCs and/or LSECs after KC depletion according to
n. Control mice consist of a mix of C57BL/6 DT-injected and Clec4fDTR/+ PBS-
trol mice n = 5 (4h), 6 (10h, 12h, 16h), 9 (8h), and 10mice (0h). KC-depleted mice
h Tukey post-test. *p < 0.05; ****p < 0.0001.
r CCL2 (white), Desmin (green), GFP (orange), F4/80 (red), and CD31 (blue) 8 h
mall amount could be found in monocytes (arrowheads) or in LSECs (asterisks).
er mm2 of tissue. Dots represent individual pictures. Pooled data are from 2
tocytes after DT injection. Given that VCAM-1was already expressed on HSCs
increase as compared with PBS control. PBS controls were included in each
n each cell population. Pooled data are from 2–4 experiments; n = 7 (4h), 8 (10h,
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to Csf1, Il34 was exclusively expressed by HSCs and was only
minimally increased upon activation (Figure S6A). IL-34 expres-
sion by HSCs was confirmed by confocal microscopy and
correlated with the location of KCs (Figure 7A). Conversely,
KCs showed expression of 3 different platelet-derived growth
factor (PDGF) molecules, a major growth factor family involved
in the survival and proliferation of stromal cells, indicating a po-
tential reciprocal loop between HSCs and KCs (Figure S6C)
(Andrae et al., 2008; Heldin and Westermark, 1999; Zhou
et al., 2018).
To narrow down the list of potential ligand-receptor interac-
tions inducing the expression of the main KC-associated tran-
scription factors, we performed 12 h co-culture experiments of
BM monocytes with HSCs, LSECs, or hepatocytes. Nr1h3,
Rxra, and Spic were induced upon co-culture with LSECs,
whereas Id3 was induced upon co-culture with hepatocytes
(Figure 7B). Given that we have recently shown that LXR-a
controls 30% of the liver-specific identity of KCs and is essen-
tial for KC survival (Scott et al., 2018), we decided to focus on
the induction of LXR-a expression by LSECs. NicheNet anal-
ysis had predicted DLL-Notch as the predominant LSEC-
monocyte interaction (Figure 6A). We decided to proceed
with DLL4 because it was the highest expressed DLL on
LSECs. Given that NicheNet predicted an important overlap
between DLL-Notch target genes and BMP target genes in
mo-KCs, we also took BMP2 and BMP9 along because these
are the main BMP molecules expressed by LSECs and HSCs,
respectively.
BM monocytes were cultured on a feeder layer of DLL4-ex-
pressing OP9 cells (OP9-DL4) or control GFP-expressing OP9
cells (OP9-GFP), in presence or absence of BMP2 or BMP9.
Expression ofNr1h3 and Spicwere induced by DLL4 stimulation
in monocytes within 12 h but failed to induce the expression of
KC-core genes (Clec4f, Cd207, Cd5l, and Cdh5) except for theFigure 5. HSCs and LSECs Activation, Monocytes Recruitment, and En
(A) Schematic representation of the NicheNet analysis of upstream ligand-recept
upstream ligands based on HSCs and LSECs DE genes; in (2) (left) are potential re
and (right) their expression in LSECs and HSCs; in (3) (top) are potential target gen
control or during KC depletion (12 h and 36 h).
(B) MIP of Clec4fDTR/+ mouse liver sections stained for CCL2 (white), Desmin (gree
(bottom). Data are representative of 2 experiments. Scale bar, 50 mm.
(C) Quantification of VCAM-1 and selectin E expression by HSCs and LSECs 10
antibody or with anti-TNF + Anakinra. VCAM-1 is represented as MFI fold increase
experiment. Selectin E is represented as percentage of positive cells in each cell po
post-test. ***p < 0.001, ****p < 0.0001.
(D) Ly6C and F4/80 expression in PBS-injected mice (PBS) or 24 h after (1) DT +
Anakinra. Flow-cytometry plots are pre-gated as in Figure 1A. Data are represen
(E) Number of Ly6Chi monocytes in the liver of Clec4fDTR/+ mice 24 h after PBS
Anakinra. Pooled data are from 3 experiments; n = 10 (PBS, anti-TNF) and 11 (Iso
test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(F) CD11c andMHCII expression on Ly6Chi monocytes in PBS-injectedmice (PBS
DT + anti-TNF + Anakinra. Flow-cytometry plots are pre-gated as in Figure 1A. D
(G) Number of Ly6Chi monocyte subsets according to CD11c and MHCII express
different combinations of isotype control, anti-TNF and Anakinra. Pooled data are
Anakinra). Two-way ANOVA with Tukey post-test. *p < 0.05, **p < 0.01, ***p < 0.
(H) Number of Ly6Chi monocytes in the liver ofClec4f+/DTR-Tnfflox/flox (n = 16) orCle
experiments. t test. *p < 0.05.
(I) Number of the different Ly6Chi monocyte subsets according to CD11c and M
Tnfflox/flox (n = 12) mice 24 h after DT injection. Pooled data are from 3 experimen
Related to Figure S5.
648 Immunity 51, 638–654, October 15, 2019LXR-a-dependent KC gene Cd38 (Figures 7C and S7A) (Scott
et al., 2018). Addition of BMP2 or BMP9 did not significantly alter
the expression of any of the tested genes. We next examined the
effect of prolonged DLL4 and BMPs stimulation by extending the
co-culture for 6 days. Although addition of BMP2 to the culture
had no effect on the genes tested, BMP9 increased the expres-
sion of Nr1h3- and of Nr1h3-dependent genes (Cd5l and Cdh5)
as well as the KC-specific gene Clec4f (mRNA only) and the
KC-core markers CD207 and CD38 (mRNA and protein) (Figures
7D, 7E, S7C, and S7D). Conversely, BMP9 did not increase the
Spic or Rxra expression (Figure S7B). Altogether these data
indicate that Notch signaling is needed to render monocytes
responsive to BMP imprinting and that BMP and Notch signaling
act in synergy to induce high Nr1h3 expression and imprint part
of the KC identity. Given that we had identified the DLL-Notch
pathway as the essential trigger to induce part of the LXR-
a-controlled KC-module in monocytes, we performed an in vivo
blockade of Notch signaling by injecting anti-DLL1 and anti-
DLL4 concomitantly with the DT. Twenty-four hours after DT in-
jection, CD11chiMHCIIhi monocytes showed significantly
decreased expression of both Nr1h3 and Spic, confirming the
relevance of Notch signaling in the acquisition of KC-associated
transcription factors in vivo (Figures 7F and S7E).
Altogether these data identify the LSEC-derived DLL-Notch
signal as a strong inducer of LXRa, SPIC, and the KC identity,
which is further amplified by BMP signaling. The main source
of BMP signal could be the BMP9 produced by HSCs.
DISCUSSION
Under homeostatic conditions, monocytes circulate in the liver
sinusoids but do not contribute to the adult KC pool (Hoeffel
et al., 2015; Schulz et al., 2012; Scott et al., 2016; Yona et al.,
2013). However, depletion of KCs induces a rapid recruitmentgraftment in the Liver Are Mediated by Both TNF and IL-1
or pairs inducing the DE genes of LSECs and HSCs. Shown in (1) are potential
ceptors expressed by HSCs and LSECs associated with each potential ligands
es of the top 3 of potential ligands and (bottom) their relative expression in PBS
n), and F4/80 (red) 8 h after DT injection + isotype (top) or Anakinra + anti-TNF
h after PBS or DT injection administrated together with either isotype control
as compared with PBS control. PBS controls were included in each individual
pulation. Pooled data from 3 experiments. n = 12. Two-way ANOVAwith Tukey
isotype control, (2) DT + Anti-TNF, (3) DT + Anakinra, or (4) DT + anti-TNF +
tative of 3 experiments.
or DT injection together with different combinations of isotype, anti-TNF, and
type, Anakinra, Anti-TNF + Anakinra). One-way ANOVA with Bonferroni post-
) or 24 h after (1) DT + isotype control, (2) DT + Anti-TNF, (3) DT + Anakinra, or (4)
ata are representative of 3 experiments.
ion in the liver of Clec4fDTR/+ mice 24 h after PBS or DT injection together with
from 3 experiments; n = 10 (PBS, anti-TNF) or 11 (Isotype; Anakinra; Anti-TNF +
001, ****p < 0.0001.
c4fCre/DTR-Tnfflox/flox (n = 12) mice 24 h after DT injection. Pooled data are from 3
HCII expression in the liver of Clec4f+/DTR-Tnfflox/flox (n = 16) or Clec4fCre/DTR-
ts. Two-way ANOVA with Tukey post-test. ****p < 0.0001.
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of BM monocytes that engraft in the liver in one single wave, ac-
quire the KC-specific genetic program, and gain the capacity to
self-maintain in the liver without any subsequent contribution of
BM monocytes (Scott et al., 2016). KC death therefore seems to
temporarily allow the engraftment and differentiation of mono-
cytes into KCs, but the precise cellular and molecular events
governing this process were unknown. Here, we used a broad
set of microscopy techniques to track monocytes developing
into KCs and identified the main cells interacting with monocytes
during that process. Next, we performed transcriptomic profiling
of these cells and utilized NicheNet to prioritize the potential
molecular signals driving the repopulation of the KC niche and
proceeded to experimentally test the strongest predictions.
We show that contrary to the general assumption, KC are not
strictly located inside the blood vessels but always extend an
important fraction of their cell body into the perisinusoidal space
of Disse where they closely interact with HSCs and hepatocytes.
The position of KCs in the space of Disse is functionally impor-
tant. KCs have been shown to deliver iron they acquire from
dying red blood cells to hepatocytes (Theurl et al., 2016). Their
position with part of their cell body on each side of the endothe-
lium provides a probable explanation for the efficient uptake of
aged red blood cells in the blood vessel and the efficient transfer
of iron to hepatocytes. Anecdotally, Karl Wilhelm von Kupffer
originally mixed-up KCs and HSCs. He first described stellar-
shaped cells on the basis of gold chloride incorporation, which
stains the retinol inside the HSCs. Later, he injected India ink
or sheep red blood cells and identified phagocytic stellar-shaped
cells, now known to be the KCs, and thought that both cells were
one same cell that he called ‘‘Sternzellen.’’ Seeing the co-local-
ization of these cells and their strong cell-cell interactions in the
space of Disse it is now easy to understand where the confusion
came from (Von Kupffer, 1876; Wake, 2004).
The Medzhitov group recently proposed that fibroblasts and
macrophages form a stable two-cell circuit in which the popula-
tion density is controlled through exchange of growth factors.
In these cultures, CSF1 is provided by fibroblasts and binds
CSF1R on macrophages that in return produce PDGF, essential
for fibroblast survival (Zhou et al., 2018). We found that under ho-
meostatic conditions HSCs are the main cellular source of CSF1
and IL-34, the two primary macrophage growth factors. Further-
more, Pdgfc is gradually expressed during mo-KCs develop-
ment. The HSC-KC interaction might thus represent the in vivo
equivalent of the in vitro cell-cell circuit described by Zhou and
colleagues. They also found that in vitro cultures starting at a
1:10macrophage-fibroblast ratio triggeredmacrophage prolifer-
ation until a stable cell-cell ratio around 1:1 was obtained (Zhou
et al., 2018). Here, we showed that monocyte engraftment was
followed by a proliferation phase until the steady-state KC den-Figure 6. CSF1 and BMP- and Notch-Signaling Pathway Serve as Pote
(A) Schematic representation of the NicheNet analysis of upstream ligand-recepto
from HSCs, LSECs, or hepatocytes based on KC-associated transcription factor
monocytes; in 2 (top) are potential receptors expressed by monocytes associated
KC during KC repopulation.
(B) Circle plot showing links between (1) predicted ligands from HSCs (green), LS
monocytes and (3) KC-associated transcription factors or DE genes (mo-KC 3d
(C) On the left are genes potentially targeted by CSF1, BMP molecules, and/or No
mo-KCs during KC repopulation.
650 Immunity 51, 638–654, October 15, 2019sity was recovered. Lowering the starting mo-KC population by
diminishing the number of available precursors (Ccr2/ mice)
or dampening the engraftment of monocytes (anti-TNF + Ana-
kinra treatment) resulted in a prolonged proliferation phase but
in the end yielded the same KC population density, thus fitting
with a stableHSC-KCcircuit that, on the basis of ourmicroscopy,
would also stabilize around a 1:1 ratio.
The engraftment of monocytes in the liver after KC depletion is
transient in nature. This short window of opportunity for engraft-
ment in the liver is explained by the transient TNF and IL-1-
dependent activation of HSCs and LSECs that induces the brief
expression of monocyte-attracting chemokines and adhesion
molecules. We have recently hypothesized that macrophage
precursors might compete for a restricted number of niches
per organ and proposed niche accessibility and niche availability
as the predominant factors determining the outcome of this
competition (Guilliams and Scott, 2017). Here, we generated
maximal niche availability by complete depletion of the KC
population. Nonetheless, only a fraction of the recruited mono-
cytes engrafted in the liver and did so only in the first few hours
after KC depletion. We feel this illustrates the importance of
niche accessibility given that in this KC repopulation model the
niche only temporarily ‘‘opens’’ when the molecules specialized
in the recruitment, arrest, and transmigration of monocytes
across the endothelial barrier are expressed.
Finally, we set out to unravel the signals driving the acquisition
of the KC-specific identity by monocytes. It was previously
shown that ID3 and LXR-a control an important part of the KC-
specific identity (Mass et al., 2016; Scott et al., 2018). We
showed that these transcription factors are acquired by en-
grafted monocytes within 24 h after KC depletion. We report
that the LSECs are the main niche cell inducing LXR-a expres-
sion in monocytes and demonstrate that DLL4-induced Notch
activation lead to the rapid expression of LXR-a in monocytes
as well as part of the KC identity. Importantly, in vivo blocking
of Notch signaling dampened the expression of the transcription
factors Nr1h3 and Spic in recruited monocytes, confirming the
role of Notch signaling in the acquisition of KC identity in vivo.
Remarkably, it has recently been reported that DLL4 expression
on LSECs is zonated, being highly expressed in the periportal re-
gion and lowly expressed around the central vein, therefore
correlating with the location of KCs (Halpern et al., 2018).
NicheNet also highlighted an important overlap between pre-
dicted BMP- and Notch-target genes. We found that Notch
signaling is needed to render the monocytes responsive to
BMP activity, because BMPs alone did not induce the expres-
sion of any of the KC-associated genes, whereas the combina-
tion between Notch and BMP9 signaling synergized to induce
high expression of Nr1h3 and Nr1h3-dependent KC genes.ntial Upstream Signals Inducing Monocyte-to-KC Differentiation
r pairs inducing the KC-specific identity. In 1, are the potential upstream ligands
s and on DE genes found between mo-KC 3 days after KC depletion and BM
with each potential ligands and (bottom) their expression in BMmono andmo-
ECs (blue), or hepatocytes (yellow) with (2) their associated receptors found on
versus BM mono) potentially targeted by the ligand-receptors pairs.
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However, HSCs and LSECs express many BMPs, so the in vivo
relevance of the different BMPs in the imprinting of the KC iden-
tity remains to be determined. Finally, we showed that Id3
expression is strongly induced in monocytes cultured with
hepatocytes. The underlying molecular pathway driving ID3
expression by the hepatocytes still has to be determined, but
the transmigration of the monocytes inside the perisinusoidal
space of Disse might be crucial to bring the monocytes in close
contact with hepatocytes and receive the signals imprinting ID3.
Altogether this study sheds light on the cell-cell interactions
governing the engraftment and tissue-specific imprinting of
monocytes differentiating into resident macrophages and em-
phasizes the differential roles of fibroblasts, endothelial cells,
and parenchymal cells in this process. The localization of an
important part of the KC body inside the space of Disse ensures
the continuous close contact of KCswith these three cells. Death
of KCs, in part through the release of TNF and IL-1, induces the
activation of HSCs and LSECs, temporarily opening the KC niche
for monocyte colonization and allowing their engraftment and
transmigration into the space of Disse. Interaction with hepato-
cytes induces ID3, whereas interaction with LSECs induces
LXR-a via the DLL4-Notch pathway. Moreover, we found that
the HSC-associated BMP9 can synergize with Notch signaling
to amplify the LXR-a-controlled KC-module. Although this re-
mains to be determined, we believe these mechanisms will
also play a role in monocyte engraftment during liver injury or in-
fections. Finally, we hope this study will represent a blueprint for
the study of cell-cell interactions in other macrophage niches
across tissues and species.
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Antibodies
Anti-armenian hamster monoclonal IgG isotype control
(Armenian hamster, clone PIP), unconjugated
Bio X Cell Cat#BE0260; RRID: AB_2687739
Anti-armenian hamster Polyclonal antibody (Goat), AF647
conjugated
Jackson ImmunoResearch Cat#127-605-160; RRID: AB_2339001
Anti-chicken IgY Polyclonal antibody (Goat), AF680 conjugated Abcam Cat#ab175779
Anti-goat Polyclonal antibody (Donkey), AF488 conjugated Thermo Fisher Cat#A-11055; RRID: AB_142672
Anti-goat Polyclonal antibody (Donkey), AF555 conjugated Thermo Fisher Cat#A-21432; RRID: AB_141788
Anti-goat Polyclonal antibody (Donkey), AF647 conjugated Thermo Fisher Cat#A-21447; RRID: AB_141844
Anti-mouse CCL2 Monoclonal antibody (Armenian hamster,
clone 2 h5), unconjugated
Biolegend Cat#505902; RRID: AB_315408
Anti-mouse CD11b Monoclonal antibody (Rat, clone M1/70),
BV605 conjugated
Biolegend Cat#101237; RRID: AB_11126744
Anti-mouse CD11b Monoclonal antibody (Rat, clone M1/70),
PE-Cy7 conjugated
BD Biosciences Cat#552850; RRID: AB_394491
Anti-mouse CD11c Monoclonal antibody (Armenian hamster,
clone N418), PE-eFluor 610 conjugated
Thermo Fisher Cat#61-0114-82; RRID: AB_2574530
Anti-mouse CD31 Monoclonal antibody (Rat, clone 390), FITC
conjugated
Thermo Fisher Cat#11-0311-82; RRID: AB_465012
Anti-mouse CD31 Monoclonal antibody (Rat, clone MEC 13.3),
unconjugated
BD Biosciences Cat#550274; RRID: AB_393571
Anti-mouse CD38 Monoclonal antibody (Rat, clone 90), Alexa
Fluor 700 conjugated
Thermo Fisher Cat#56-0381-82; RRID: AB_657740
Anti-mouse CD41 Monoclonal Antibody (Rat, clone MWReg30),
Unconjugated
BD Biosciences Cat#553847; RRID: AB_395084
Anti-mouse CD45 Monoclonal antibody (Rat, clone 30-F11),
AF700 conjugated
Thermo Fisher Cat#56-0451-82; RRID: AB_891454
Anti-mouse CD45 Monoclonal antibody (Rat, clone 30-F11),
BV510 conjugated
Biolegend Cat#103138; RRID: AB_2563061
Anti-mouse CD45 Monoclonal antibody (Rat, clone 30-F11),
PE-Cy7 conjugated
Thermo Fisher Cat#25-0451; RRID: AB_469625
Anti-mouse CD54 (ICAM-1) Monoclonal antibody (Rat, clone
YN1/1.7.4), AF488 conjugated
Biolegend Cat#116111; RRID: AB_493494
Anti-mouse CD61 Monoclonal antibody (Hamster, clone
2C9.G2), PE conjugated
Biolegend Cat#104308; RRID: AB_313085
Anti-mouse CD62E (Selectin E) Monoclonal antibody (Rat,
clone 10E9.6), PE conjugated
BD Biosciences Cat#553751; RRID: AB_395031
Anti-mouse CD64 Monoclonal antibody (Mouse, clone
X54-5/7.1) BV711 conjugated
Biolegend Cat#139311; RRID: AB_2563846
Anti-mouse CD106 (VCAM-1) Monoclonal Antibody
(Rat, clone 429), AF647 conjugated
Biolegend Cat#105712; RRID: AB_493429
Anti-mouse CD115 (c-fms) Monoclonal antibody (Rat, clone
AFS98), PerCP-eFluor 710 conjugated
Thermo Fisher Cat#46-1152-82; RRID: AB_10597740
Anti-mouse CD140b (PDGFRb) Monoclonal antibody
(Rat, clone APB5) Biotin conjugated
Thermo Fisher Cat#13-1402-82; RRID: AB_466609
Anti-mouse CD146 Monoclonal antibody (Rat, clone ME-9F1),
APC conjugated
Biolegend Cat#134712; RRID: AB_2563088
Anti-mouse CD172a (Sirpa) Monoclonal antibody
(Rat, clone P84), unconjugated
BD Biosciences Cat#552371; RRID: AB_394371
(Continued on next page)
Immunity 51, 638–654.e1–e9, October 15, 2019 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Anti-mouse CD207 Monoclonal antibody (Rat, clone 929F3.01),
Alexa Fluor 647 conjugated
IMGENEX Cat#DDX0362A647; RRID: AB_1148741
Anti-mouse Clec4F Polyclonal antibody (Goat), unconjugated R&D Systems Cat#AF2784; RRID: AB_2081339
Anti-mouse Desmin Polyclonal antibody (Goat), unconjugated R&D Systems Cat#AF384; RRID: AB_2092419
Anti-mouse Desmin Polyclonal antibody (Rabbit), unconjugated Abcam Cat#ab15200; RRID: AB_301744
Anti-mouse DLL1 Monoclonal antibody (Armenian hamster,
clone HMD1-5), unconjugated
Bio X Cell Cat#BE0155; RRID: AB_10950546
Anti-mouse DLL4 Monoclonal antibody (Armenian hamster,
clone HMD4-2), unconjugated
Bio X Cell Cat#BE0127; RRID: AB_10950366
Anti-mouse F4/80 Monoclonal antibody (Rat, clone BM8),
AF594 conjugated
Biolegend Cat#123140; RRID: AB_2563241
Anti-mouse F4/80 Monoclonal antibody (Rat, clone BM8),
BV785 conjugated
Biolegend Cat#123141; RRID: AB_2563667
Anti-mouse F4/80 Monoclonal antibody (Rat, clone BM8),
biotin conjugated
eBioscience Cat#13-4801-85; RRID: AB_466657
Anti-mouse GFP Polyclonal antibody (Chicken), unconjugated Aves Labs Cat#GFP-1010; RRID: AB_2307313
Anti-mouse I-A/I-E (MHCII) Monoclonal antibody (Rat, clone
M5/114.15.2), Alexa Fluor 700 conjugated
Thermo Fisher Cat#56-5321-82; RRID: AB_494009
Anti-mouse I-A/I-E (MHCII) Monoclonal antibody (Rat, clone
M5/114.15.2), Biotin conjugated
BioLegend Cat#107604; RRID: AB_313319
Anti-mouse I-A/I-E (MHCII) Monoclonal antibody (Rat, clone
M5/114.15.2), FITC conjugated
Thermo Fisher Cat#11-5321-85; RRID: AB_465233
Anti-mouse I-A/I-E (MHCII) Monoclonal antibody (Rat, clone
M5/114.15.2), unconjugated
Biolegend Cat#107602; RRID: AB_313317
Anti-mouse IL-1 alpha Polyclonal antibody (Rabbit), unconjugated Abcam Cat#ab9724; RRID: AB_308766
Anti-mouse IL-1 beta Polyclonal antibody (Goat), unconjugated R&D Systems Cat#AF-401-NA; RRID: AB_416684
Anti-mouse IL-34 Polyclonal antibody (Sheep), unconjugated R&D Systems Cat#AF5195; RRID: AB_2124393
Anti-mouse Ki-67 Monoclonal antibody (Mouse, clone B56),
PerCP-Cy5.5 conjugated
BD Biosciences Cat#561284; RRID: AB_10611574
Anti-mouse Ki-67 Monoclonal antibody (Rat, clone TEC-3),
unconjugated
Agilent Cat#M7249; RRID: AB_2250503
Anti-mouse Ly6C Monoclonal antibody (Rat, clone HK1.4),
eF450 conjugated
Thermo Fisher Cat#48-5932-82; RRID: AB_10805519
Anti-mouse Ly6C Monoclonal antibody (Rat, clone HK1.4),
PE conjugated
BD Biosciences Cat#560592; RRID: AB_1727556
Anti-mouse Ly6G Monoclonal antibody (Rat, clone 1A8),
AF700 conjugated
BD Biosciences Cat#561236; RRID: AB_10611860
Anti-mouse Ly6G Monoclonal antibody (Rat, clone 1A8),
PE conjugated
BD Biosciences Cat#551461; RRID: AB_394208
Anti-mouse Lyve-1 Polyclonal antibody (Goat), unconjugated R&D Systems Cat#AF2125; RRID: AB_2297188
Anti-mouse Lyve-1 Monoclonal antibody (Rat, clone ALY7),
Biotin conjugated
Thermo Fisher Cat#13-0443-82; RRID: AB_1724157
Anti-mouse Lyve-1 Monoclonal antibody (Rat, clone ALY7),
eFluor660 conjugated
Thermo Fisher Cat#50-0443-82; RRID: AB_10597449
Anti-mouse M-CSF Polyclonal antibody (Goat), unconjugated R&D Systems Cat#AF416; RRID: AB_355351
Anti-mouse Siglec F Monoclonal antibody (Rat, clone E50-2440)
BUV395 conjugated
BD Biosciences Cat#740280; RRID: AB_2740019
Anti-mouse Siglec F Monoclonal antibody (Rat, clone E50-2440)
PE conjugated
BD Biosciences Cat#552126; RRID: AB_394341
Anti-mouse Tim-4 Monoclonal antibody (Rat, clone RMT4-54),
PerCP-Cy5.5 Conjugated
Thermo Fisher Cat#46-5866-82; RRID: AB_2573781
Anti-mouse TNFa Monoclonal antibody (Rat, clone XT3.11),
unconjugated
Bio X Cell Cat#BE0058; RRID: AB_1107764
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Anti-rabbit Polyclonal antibody (Donkey), AF488 conjugated Jackson ImmunoResearch Cat#711-546-152; RRID: AB_2340619
Anti-rabbit Polyclonal antibody (Donkey), AF647 conjugated Thermo Fisher Cat#A-21244; RRID: AB_2535812
Anti-rat Polyclonal antibody (Donkey), AF488 conjugated Thermo Fisher Cat#A-21208; RRID: AB_2535794
Anti-rat Polyclonal antibody (Donkey), Cy3 conjugated Jackson ImmunoResearch Cat#712-166-153; RRID: AB_2340669
Anti-sheep Polyclonal antibody (Donkey), AF647 conjugated Thermo Fisher Cat#A-21448; RRID: AB_2535865
Chemicals, Peptides, and Recombinant Proteins




Cacodylate (Sodium)buffer 0,2M pH7.4 EMS Cat#11652
Calcium chloride Sigma-Aldrich Cat#449709
Collagenase A Sigma-Aldrich Cat#11088793001
Corn oil Sigma-Aldrich Cat#C8267
Corning Collagen I, Bovine Corning Cat#354231
D-(+)-Glucose Sigma-Aldrich Cat#D9434
DAPI Thermo Fisher Cat#D3571
Diphtheria toxin Sigma-Aldrich Cat#D0564
DMEM/F12 ThermoFisher Cat#11320074
Dnase I Sigma-Aldrich Cat#04 536 282 001




FC block (clone 2.4G2) Bioceros N/A
Fetal Bovine Serum (South America), Gamma Irradiated Bodinco S181G
Gentamicin GIBCO Cat#15710-049
GlutaMAX Life Technologies Cat#35050-038
Glutamine Lonza Cat#BE17-605F
Gluteraldehyde 25% Sigma-Aldrich Cat#G5882
Goat serum Sigma-Aldrich Cat#G9023
HEPES Sigma-Aldrich Cat#H3375
L-Aspartic Acid Sigma-Aldrich Cat#A8949
Lead (II) Nitrate Sigma-Aldrich Cat#07905CJ
M-CSF VIB Protein Service Facility N/A
MEM alpha GIBCO Cat#22571-020
Osmium Tetroxide 4% EMS Cat#19150
Paraformaldehyde 10% EMS Cat#15712
Penicillin-streptomycin GIBCO Cat#15140-122
PLX3397 Achemblock Cat#H-8970
Phenol Red Sigma-Aldrich Cat#P3532
Potassium chloride Sigma-Aldrich Cat#P9541
Potassium Ferricyanide EMS Cat#20150
ProLong Diamond Thermo Fisher Cat#P36970
Rat serum Sigma-Aldrich Cat#R9759
Recombinant Human/Mouse/Rat BMP-2 Protein RnD Systems Cat#355-BM-010
Recombinant Human/Mouse/Rat BMP-9 Protein RnD Systems Cat#5566-BP-010
RPMI Thermo Fisher Cat#21875-059
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Saponin Sigma-Aldrich Cat#4521
Sodium bicarbonate Sigma-Aldrich Cat#792519
Sodium chloride Sigma-Aldrich Cat#746398
Sodium Dihydrogen Phosphate Monohydrate Sigma-Aldrich Cat#000000001063461000
Sodium phosphate dibasic dihydrate Sigma-Aldrich Cat#71643
Streptavidin, BV605 conjugated BD Biosciences Cat#563260
Streptavidin, PE-CF594 conjugated BD Biosciences Cat#562284
Thiocarbohydrazide EMS Cat#21900
Tissue-Tek O.C.T Sakura Finetek Cat#4583
Trypsin-EDTA (0,25%), phenol red GIBCO Cat#25200072
Uranyl Acetate Replacement EMS Cat#22405
Critical Commercial Assays
ALLin HS Red Taq Mastermix 2x highQu Cat#HQ.HSM0350
Click-iT Plus EdU Alexa Fluor 647 Thermo Fisher Cat#C10634
Live/Dead eFluor 780 Thermo Fisher Cat#65-0865-18
MCP-1/CCL2 Mouse Uncoated ELISA Kit Thermo Fisher Cat#88-7391-88
RNEasy Plus Micro Kit QIAGEN Cat#74034
Sensifast cDNA synthesis kit Bioline Cat#BIO-65054
SensiFAST sybr no-ROX mix Bioline Cat#BIO-98020
Deposited Data
Murine RNA-sequencing data This paper GEO: GSE135790
Murine Micro-array data This paper GEO: GSE135790
Experimental Models: Cell Lines
OP9-DL4 Gift from Tom Taghon Van de Walle et al., 2011
OP9-GFP Gift from Tom Taghon Van de Walle et al., 2011
Experimental Models: Organisms/Strains
Mouse: C57BL/6j SPF Janvier Labs N/A
Mouse: B6(C)-Ccr2 tm1.1Cln/J The Jackson Laboratory JAX: 027619
Mouse: B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J JAX: 007905
Mouse: Clec4f-cre CIPHE, Marseille, France
Mouse:B6-Clec4fhDTR/YFP-CIPHE CIPHE, Marseille, France
Mouse: Tnf tm1.1Sned Grivennikov et al., 2005
Oligonucleotides
Nr1 h3 qPCR FWD: N/A CAAGGGAGCACGCTATGTCTG
Nr1 h3 qPCR REV: N/A GGACACCGAAGTGGCTTGAG
Rxra qPCR FWD: N/A GATATCAAGCCGCCACTAGG
Rxra qPCR REV: N/A TTGCAGCCCTCACAACTGTA
Id3 qPCR FWD: N/A CTGTCGGAACGTAGCCTGG
Id3 qPCR REV: N/A GTGGTTCATGTCGTCCAAGAG
Spic qPCR FWD: N/A AAACATTTCAAGACGCCATTGAC
Spic qPCR REV: N/A CTCTGACGTGAGGATAAGGGT
B2m qPCR FWD: N/A CGGCCTGTATGCTATCCAGAA
B2m qPCR REV: N/A GGCGGGTGGAACTGTGTTA
Cd5l qPCR FWD: N/A GAGGACACATGGATGGAATGT
Cd5l qPCR REV: N/A ACCCTTGTGTAGCACCTCCA
Actb qPCR FWD: N/A GCTTCTAGGCGGACTGTTACTGA
Actb qPCR REV: N/A GCCATGCCAATGTTGTCTCTTAT
Clec4f qPCR FWD: N/A GAGGCCGAGCTGAACAGAG
(Continued on next page)
e4 Immunity 51, 638–654.e1–e9, October 15, 2019
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Clec4f qPCR REV: N/A TGTGAAGCCACCACAAAAAGAG
Cd207 qPCR FWD: N/A CCGAAGCGCACTTCACAGT
Cd207 qPCR REV: N/A GCAGATACAGAGAGGTTTCCTCA
Cd38 qPCR FWD: N/A TCTCTAGGAAAGCCCAGATCG
Cd38 qPCR REV: N/A GTCCACACCAGGAGTGAGC
Cdh5 qPCR FWD: N/A CACTGCTTTGGGAGCCTTC
Cdh5 qPCR REV: N/A GGGGCAGCGATTCATTTTTCT
Software and Algorithms
FlowJo v11 FlowJo https://www.flowjo.com
GraphPad Prism 7 GraphPad Software https://www.graphpad.com/
Icy N/A http://icy.bioimageanalysis.org/
ImageJ v1.51j NIH https://imagej.nih.gov/ij
Imaris v7.6.4 Bitplane: Imaris www.bitplane.com




Microscopy Image Browser N/A http://mib.helsinki.fi/
NicheNet N/A https://zenodo.org/record/1484138LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to, andwill fulfilled by, the Lead Contact, Martin Guil-
liams (martin.guilliams@irc.ugent.be).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
In Vivo Animal Studies
The following mouse models were used; Clec4fDTR (Scott et al., 2016), Clec4fCRE (Scott et al., 2018), Rosa26TdT/+ (Madisen et al.,
2010), CCR2GFP/+ (Satpathy et al., 2013), TNFflox/flox (Grivennikov et al., 2005). All mice were used on a C57BL/6 background and
a mix of male and female mice were used for each experiment. Mice were used between 6 and 10 weeks of age. All mice were
bred and maintained at the VIB (Ghent University) under specific pathogen free conditions. All animals were randomly allocated
to experimental groups and littermate controls were used in all experiments. All experiments were performed in accordance with
the ethical committee of the Faculty of Science of the VIB (EC2016-052; EC2017-096).
METHODS DETAILS
Isolation of liver leukocytes
Livers were isolated from PBS-perfused mice, chopped finely and subjected to GentleMACS dissociation and incubated for 20 min
with 1 mg/mL Collagenase A (Sigma) and 10U/mL DNase (Roche) in a shaking water bath at 37C. Following a second round of
GentleMACS dissociation, single cell suspensions were filtered over a 100 mm filter.
Isolation of HSCs, LSECs and Hepatocytes
Hepatocytes, LSECs and HSCs isolation procedure was adapted from Mederacke et al. (Mederacke et al., 2015). After retrograde
cannulation, livers were first perfused with a EGTA-containing solution for 1–2 min following by a perfusion with 0,2 mg/mL
collagenase A-containing solution for 5 min (6 mL/min). Livers were minced and incubated 20 min with 0,4 mg/mL Collagenase
A and 10U/mL DNase in a water bath at 37C. All the subsequent procedures were at 4C. After filtration with a 100 mm mesh filter,
the cell suspensionswere centrifuged at 400 g for 7min and re-suspended in 2mL of red blood lysis buffer for 2min to remove any red
blood cells left. Suspensions were washed in PBS and further filtered on a 40 mmmesh filter and centrifuged twice for 1 min at 50 g
resulting in an hepatocytes-enriched fraction (pellet) and a leukocytes/LSECs/HSCs-enriched fraction (supernatant). Both fractions
were further centrifuged at 400 g for 7 min before to proceeding to FACS staining.Immunity 51, 638–654.e1–e9, October 15, 2019 e5
Isolation of BM monocytes
Bone-marrow was isolated from the tibia and femur of mice by flushing the bones with RPMI 1640 (GIBCO). Red blood cells were
lysed and single cell suspensions were stained with fluorescently labeled antibodies. BM monocytes were sorted based on
CD45, Ly6C, CD115, and CD11b expression.
Flow Cytometry
Cells (0.5–5x106) were pre-incubated with 2.4G2 antibody (Bioceros) to block Fc receptors, stained with appropriate antibodies at
4C in the dark for 30 min and permeabilized for KI-67 and EDU staining according to the manufacturer’s protocol (Click-iT Plus
EdU, Thermo Fisher). Cell viability was assessed using Fixable Viability dye eFluor780 (Thermo Fisher) and the cell suspensions
were analyzed with a Fortessa or a FACSymphony (BD Biosciences) and FlowJo software (TreeStar). Retinol fluorescence was visu-
alized using a 405–407 nm laser for excitation and a 450/50 nm band-pass filter for detection. KCs/HSCs/LSECs/hepatocytes were
sorted using an ARIA II or ARIA III (BD, Biosciences) with a purityR 90% (not shown). The full list of antibodies used can be found in
the Key Resources Table.
Liver cells and monocytes co-culture
HSCs, LSECs, hepatocytes and BMmonocytes fromCCR2GFP/+ mice were sorted in RPMI 1640 supplemented with 10% FCS (Bod-
inco) using an ARIA II or ARIA III. Cells were then resuspended in DMEM/F12 (GIBCO) supplemented with 10% FCS, 30 ng/mL CSF1
(VIB Protein Service Facility), 2 mM Glutamine (Lonza), 100 U/mL penicillin (GIBCO) and 100 mg/mL streptomycin (GIBCO). 1x105
monocytes were seeded in bovine collagen type I-coated (Corning) round bottom 96-well plates either alone or at a 1:1 ratio with
HSCs, LSECs or hepatocytes in a final volume of 200 ml culture medium and incubated for 12 h (37C, 5% CO2). After incubation,
cells were harvested with 0,25% Trypsin-EDTA (GIBCO) and GFP+ cells were sorted in RLT plus (QIAGEN) containing 1% b-mercap-
toethanol (Sigma) with the FACSAria III and stored at 80C.
OP9 cells and monocytes co-culture
OP9-GFP and OP9-DL4 were cultured in MEMa (GIBCO) supplemented with 20% FCS, 1x GlutaMAX (GIBCO) and 0,056 mg/mL
Gentamicin ( = cMEMa). Two days prior to the coculture, 2x103 or 2,5x104 OP9-GFP cells and OP9-DL4 cells were seeded in sepa-
rate wells of a 96-well U-bottom plates or 12-well plates respectively to generate a feeder layer. BM monocytes from C57BL/6 mice
were sorted in RPMI 1640 supplemented with 10% FCS (Bodinco) using an ARIA III. Cells were then resuspended in MEMa (GIBCO)
supplemented with 20% FCS, 1x GlutaMAX and 0,056 mg/mL Gentamicin. For 12 h coculture experiments, 1x105 monocytes were
seeded on an OP9-GFP or OP9-DL4 feeder layer in a 96-well plate in the presence of 30 ng/mL CSF1 alone or together with either
BMP2 (50 ng/mL) or BMP9 (50 ng/mL) (RnD Systems). For 6 day coculture experiments, 2x105 monocytes were seeded on an OP9-
GFP or OP9-DL4 feeder layer in a 12-well plate in the presence of 30 ng/mL CSF1 together with either BMP2 (50 ng/mL) or BMP9
(50 ng/mL) (RnD Systems). After 3 days, half of the medium was refreshed with cMEMa containing 30 ng/mL CSF1 alone or together
with either BMP2 (50 ng/mL) or BMP9 (50 ng/mL). Cells were harvested with pre warmed PBS-0.04% EDTA. For 12 h cocultures,
Ly6Chi monocytes were sorted in RLT containing 1% b-mercaptoethanol with the FACSAria III and stored at 80C. For 6 days
cocultured, total cells were analyzed and CD45+GFP cells were sorted in RLT containing 1% b-mercaptoethanol with the
FACSAria III and stored at 80C.
Confocal microscopy
Immediately after mice sacrifice, inferior vena cava were cannulated and livers were perfused (4 mL/min) with Antigenfix (Diapath) for
5 min at room temperature. After excision, 2-3 mm slices of livers were further fixed by immersion in Antigenfix for 1 h at 4C, washed
in PBS, infused overnight in 30% sucrose and frozen in Tissue-Tek OCT compound (Sakura Finetek). 20 mm-thick slices were cut on
cryostat (Microm HM 560, Thermo Scientific). Slices were rehydrated in PBS for 5 min, permeabilized with 0,5% saponin and
unspecific binding sites were blocked for 30 min with 2% bovine serum albumin, 1% fetal calf serum and 1% donkey or goat serum.
Liver sections from anti-TNF/Anakinra-treated mice or isotype control-treated mice were first incubated with the Fab fragment of
donkey anti-rat IgG (Jackson immunoresearch) to prevent the detection of rat anti-TNF or rat isotype with anti-rat secondary
antibodies. Tissue sections were then labeled overnight at 4C with primary antibodies followed by incubation for 1 h at room tem-
perature with secondary antibodies and DAPI. Slides were mounted in ProLong Diamond, imaged with a Zeiss LSM 780 confocal
microscope (Carl Zeiss) and analyzed using ImageJ v1.51 and iMaris v7.6.4 software.
Correlative light-electron microscopy
CLEMwas performed using a workflow as described by Urwyler et al., (2015). In brief, mice were intravenously injected with 20 mg of
CD31-conjugated antibody to stain sinusoid blood vessels. After 5 min, mice were sacrificed and inferior vena cava were cannulated
and livers were perfused (4 mL/min) with Antigenfix (Diapath) for 5 min at room temperature. After excision, 2-3 mm slices of livers
were further fixed by immersion in Antigenfix for 1 h at 4C,washed in PBS and slicedmaking use of Leica Vibratome VT1200S. Slices
were first used for Near Infra-Red Branding to indicate a region of interest (ROI), making use of a Zeiss LSM780 with a MaiTai laser
(Bishop et al., 2011). Next, high resolution confocal stacks were obtained with a Zeiss LSM880 FastAiry. The sample was then
processed for volume EM by fixation with Karnovsky buffer and en bloc heavy metal staining as described by Steeland et al.,
(Steeland et al., 2018). The sample was mounted onto an aluminum pin and trimmed for imaging with a Zeiss Merlin with 3View2e6 Immunity 51, 638–654.e1–e9, October 15, 2019
(Gatan). Overlays of confocal and volume EM datasets was performed based on blood vessel staining, using the ec-CLEM plugin of
ICY in order to identify Kupffer cells or monocytes (Paul-Gilloteaux et al., 2017). The EM datasets were segmented in MIB (Belevich
et al., 2016) and 3D rendering was done in iMaris.
Intravital microscopy
Mice were anesthetized with a 50 mL intraperitoneal injection of a ketamine/xylazine cocktail (3.3 mg ketamine, 0.3 mg xylazine). The
surgical area was then cleared by trimming the hairs. For imaging, mice were held in a custom-built stabilization device and further
anesthetized with isoflurane. The liver was surgically exposed in the imaging chamber at 36C and continuously superfused with
36CPBS. Imaging was performed on a LSM710 confocal microscope (Carl Zeiss) equippedwithMaiTai Deep-Seemultiphoton laser
(Spectra-Physics) and excitation wavelength at 920 nm. Images were analyzed with ImarisTrack (Bitplane) to quantify cell speeds
over time.
Microarray
2,5 3 104 cells of each population shown in Figure 2D were sorted into 500 ml RLT buffer (QIAGEN). RNA was isolated using the
RNeasy micro kit (QIAGEN) and sent to the Nucleomics facility, VIB Leuven, Belgium where the microarrays were performed using
the GeneChip Mouse Gene 1.0 ST arrays (Affymetrix). Samples were subsequently analyzed using R/Bioconductor. All samples
passed quality control, and the Robust Multi-array Average (RMA) procedure was used to normalize data within arrays (probeset
summarization, background correction and log2-transformation) and between arrays (quantile normalization). Only probesets that
mapped uniquely to one gene were kept, and for each gene, the probeset with the highest expression was kept. For the heatmaps,
the relative expression values were calculated by calculating the mean expression per gene and subtracting this mean value from
each log2 normalized value of that gene.
Bulk RNA Sequencing
2,5 3 104 HSCs, LSECs or hepatocytes were FACS-purified into 500 ml of RLT plus buffer (QIAGEN) and b-mercaptoethanol. RNA
was isolated using a RNeasy Plus micro kit (QIAGEN) and sent to the VIB Nucleomics facility, where the RNA sequencing was per-
formed using a NextSeq sequencer (Illumina). The pre-processing of the RNA sequencing data was done by Trimmomatic. The
adapters were cut and readswere trimmedwhen the quality dropped below 20. Readswith a length < 35were discarded. All samples
passed quality control based on the results of FastQC. Reads were mapped to the mouse reference genome via Tophat2 and
counted via HTSeqCount. The bulk RNA-seq data was divided in 2 experiments: the HSC and LSEC versus hepatocytes. Experi-
ments were normalized separately using the default limma (voom) procedure. For the HSC-LSEC data 1 replicate was removed:
LSEC_36 h_4, due to strange clustering behavior. For the hepatocyte data specifically we did an extra batch correction using the
sva R package (ComBat), where replicates 1 and 2 form the first batch and replicates 3 and 4 form the 2nd batch. For visualization
(PCA and heatmaps), we merged the normalized values of both experiments. Principal component analysis plot was created using
the 25%of genes with themost variable expression. Genes that were present in the HSC-LSEC-normalized expression table, but not
in the hepatocyte normalized expression table were assigned the minimal log2 value for the hepatocytes samples. The same for the
genes present in the hepatocyte-normalized expression table, but absent in the HSC-LSEC normalized expression table. The DE
genes were calculated on the separate normalized expression tables and defined based a logFC cutoff > 1 or <1 and adj.P value <
0.05. For the heatmaps we transformed the normalized expression table as ‘log2(2^expTable + 1)’ and did an extra transformation by
putting these values on a 0-1 scale. For the heatmap Figure S4A we combined all DE genes for each cell type (HSC, LSEC and he-
patocyte) and kept the DE geneswith a logFC > 1.5 or <1.5.We first looked for the overlappingDE genes between the cell types and
then took the top 50 DE genes unique for each cell type.
NicheNet analysis
NicheNet is a method that predicts which ligands produced by one cell regulate the expression of which target genes in another cell.
Ligand-target links are inferred by combining bulk or single-cell expression data of interacting cells with existing knowledge on
signaling and gene regulatory networks.
A first question NicheNet can address, is predicting which ligands produced by a sender cell are the most active in affecting gene
expression in the receiver cell (i.e., ligand activity analysis). For this, NicheNet assesses how well these ligands predict the observed
changes in gene expression and ranks them according to this. After ligand prioritization, NicheNet infers active ligand-target links by
looking for genes that are affected in the receiver cell and have a high potential to be regulated by the prioritized ligands. An open
source R implementation of NicheNet is available at GitHub (https://github.com/saeyslab/nichenetr).
NicheNet ligand activity prediction to prioritize ligands regulating activation of HSC and LSEC after KC depletion
To perform NicheNet ligand activity analysis, we need to define a list of potentially active ligands and sets of affected and
non-affected background genes in the receiving cell. NicheNet will then rank ligands according to how well they predict whether
a gene belongs to the gene set of interest compared to the background gene set. As potentially active ligands for regulating respec-
tively HSC or LSEC activation, we considered all ligands in the NicheNet model for which at least one specific receptor was ex-
pressed in respectively HSC or LSEC (average log2 expression value > 4). Receptors of ligands were determined by querying the
ligand-receptor data sources of NicheNet after excluding the data sources containing predicted ligand-receptor interactions. As
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and 12 h after KC depletion (adjusted p value% 0.05 and javerage log2 fold changej > = 1; expressed in at least 10% KCs single
cells). As background, we considered all other genes that are not differentially expressed. Ligand activity scores were then calculated
both for the HSC and LSEC setting as the pearson correlation coefficient between the ligand-target regulatory potential scores of
each selected ligand and the target indicator vector, which indicates whether a gene belongs to the gene set of interest or not. To
make the activity scores of the HSC and LSEC settings comparable, z-score normalization of the pearson correlation coefficients
was performed.
Heatmap visualization of NicheNet analysis to prioritize ligands regulating activation of HSC and LSEC after KC
depletion
In the heatmaps, the top 5 ligands for the HSC setting (out of 284 ligands) and top 5 ligands for the LSEC setting (out of 245 ligands)
are shown. Ligands are ordered according to the average z-score over both settings. For those ligands, the corresponding receptors
are indicated in the ligand-receptor heatmap. The indicated score accords to the weight of the interaction between the ligand and
receptor in the integrated weighted ligand signaling network of NicheNet. In the ligand-target heatmap, we show regulatory potential
scores for interactions between the top-ranked ligands and following target genes: genes that are differentially expressed in HSC or
LSEC (and with average log2 expression value > 4) and belong to the 150 most strongly predicted targets of Tnf or Il1a or Il1b (out of
17330 possible genes). As cutoff on the ligand-target regulatory potential, we chose theminimal regulatory potential score among the
interactions between Tnf, Il1a, Il1b and each of their respective 150 top targets.
NicheNet ligand activity prediction to prioritize niche ligands regulating monocyte to KC differentiation
To investigate the role of the different niche cell types in regulating monocyte to KC differentiation, we performed a NicheNet ligand
activity analysis for every niche cell type separately, once for prioritizing ligands regulating genes that are differentially expressed
during differentiation and once for ligands regulating a set of core KC TFs. We considered once HSC-specific, once LSEC-specific
and once hepatocyte-specific ligands as potentially active ligands if at least one specific receptor was expressed in monocytes
(average log2 expression value > 6). Cell-type specific ligands were determined as ligands that are stronger expressed in the cell
type of interest compared with both other cell types (log2 fold change > 0.5 and adjusted p value% 0.05 and average log2 expression
value > 4). Receptors of ligands were determined by querying the ligand-receptor data sources of NicheNet after excluding the data
sources containing predicted ligand-receptor interactions. As target gene sets, we considered once the list of genes that are differ-
entially expressed between monocytes and mo-KCs 3 days after KC depletion (adjusted p value% 0.05; jlog2 fold changej > = 1;
expressed in at least 10% of mature KC single cells) and once the list of the top 20 prioritized KC TFs. As background, we considered
all other genes that are not differentially expressed. Ligand activity scores were then calculated both for the differentially expressed
genes and KC TFs setting as the Pearson correlation coefficient between the ligand-target regulatory potential scores of each
selected ligand and the target indicator vector, which indicates whether a gene belongs to the gene set of interest or not. To
make the activity scores of both settings comparable over all ligands, z-score normalization of the Pearson correlation coefficients
was performed after pooling the ligands for the different cell types together.
Heatmap visualization of NicheNet niche ligands regulating monocyte to KC differentiation
In the heatmaps, the 5 top-ranked HSC, LSEC and hepatocyte-specific ligands (out of respectively a total of 37, 55 and 20 ligands)
were shown for the analyses on both differentially expressed genes and KC TFs. Ligands are ordered according to the average
z-score over both settings. For those ligands, the corresponding receptors are indicated in the ligand-receptor heatmap. The
indicated score accords to the weight of the interaction between the ligand and receptor in the integrated weighted ligand signaling
network of NicheNet. In the ligand-target heatmap, we show regulatory potential scores for interactions between a subset of the top-
ranked ligands and following target genes: KC TFs and genes that are differentially expressed between monocytes and mo-KCs
3 days after KC depletion and that also belong to the 100 most strongly predicted targets of Bmp5, Bmp4, Inhbc, Gdf2, Gdf6,
Bmp2, Bmp6, Inhbb, Bmp10, Dll1, Dll4 or Csf1 (out of 17330 possible genes). As cutoff on the ligand-target regulatory potential
scores for Csf1, we chose the minimal regulatory potential score among the interactions between Csf1 and its respective 100 top
targets. For the ligands of the Bmp and Delta-like family, we chose the minimal regulatory potential score among the interactions
between each of those ligands and their respective 100 top targets.
Circular visualization of prioritized ligand-target links
For circular visualization of the links between niche cell ligands and KC genes, the circlize R package was used (Gu et al., 2014). We
show the 5 top-ranked HSC, LSEC and hepatocyte-specific ligands for the analyses on both differentially expressed genes and KC
TFs. For those ligands, we also show the target genes divided in three groups: the group of genes that are predominantly targets of
Csf1, Bmp-Delta-Notch or of one of the other top-ranked ligands. As target genes, we show the genes that belong to the set of KC
TFs and genes that are differentially expressed between monocytes and mo-KCs 3 days after KC depletion and that also belong to
the 100 most strongly predicted targets of the prioritized ligands. We show only target genes and ligands if they have at least one
interaction with regulatory potential score > 0.00399. Links between ligands and targets are only drawn when the target belongs
to the top 100 target genes of that ligand and the regulatory potential score > 0.0045. Width of sectors and links are determined
as the sum of the regulatory potential scores. In addition to the target genes of the prioritized ligands, we also show their specific
receptors expressed in monocytes. The width of the sectors for every receptor group was determined such that ratio between
the three different groups was the same as for the targets. Within one receptor group, the width is proportional to the ligand-receptor
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Gene expression analysis by real-time RT-PCR
RNA was purified from 2,5x104 sorted cells using a RNeasy Plus micro kit (QIAGEN). RNA was reverse transcribed to cDNA with
a Sensifast cDNA synthesis kit (Bioline). Gene expression was assayed by real-time RT-PCR using a SensiFast SYBR No-Rox kit
(Bioline) on a PCR amplification and detection instrument (LightCycler 480; Roche) with the primers listed in the Key Resources Table.
Gene expression was normalized to B2m, and the mean relative gene expression was calculated using the 2DDC(t) method.
Chemicals treatments
For KC depletion, mice were intraperitoneally (IP) injected with a single dose of 500 ng of DT (Sigma) or PBS for control mice. For TNF
and IL-1 blocking experiments, 20 mg/kg of Anti-TNF-blocking antibody (Bio X Cell), 100 mg/kg of Anakinra or 20 mg/kg of isotype
control (Bio X Cell) were given to mice intraperitoneal concomitant to DT injection. For EdU (Thermo Fisher) experiment, mice were IP
injected with 1mg/mouse of EdU 4 h before sacrifice. For DDL1/4 blocking experiments, 1 mg of of DLL1 (BioXcell) and 1mg of DLL4
(BioXCell) or 2 mg of polyclonal Armenian hamster IgG isotype (BioXCell) were injected 24 h before DT injection. For CSF1R blocking
experiments, 100 mg/kg of PLX3397 was given by gavage 24 h and 48 h after DT injection.
Serum CCL2 measurement
Mice were injected with DT at the indicated time points. Blood was collected and kept at room temperature for 30 min to allow the
blood to clot. The serumwas then separated from the clot by centrifuging the tubes for 10 min at 2000 g. Resulting serums were then
kept at 80C.
QUANTIFICATION AND STATISTICAL ANALYSIS
To determine the monocytes size, maximum intensity Z-projections pictures were thresholded and individual monocytes were
measured using ImageJ. To quantify the number of CCL2 or CSF1-expressing cells, Z stacks were analyzed slice by slice to deter-
minewhich cells were containing themolecules. Results were normalized permm2 of tissue. In all experiments, data are presented as
means ± SD. Statistical tests were selected based on appropriate assumptions with respect to data distribution and variance char-
acteristics. Student’s t test withWelch correction (two-tailed) was used for the statistical analysis of differences between two groups.
One-way ANOVA with Bonferroni post-test was used for the statistical analysis of differences between more than two groups. Two-
way ANOVA with Tukey post-test was used for the statistical analysis of differences between more than two groups and with 2
different independent variables. Statistical significance was defined as p < 0.05. Sample sizes were chosen according to standard
guidelines. Number of animals is indicated as ‘‘n.’’ Of note, sizes of the tested animal groups were also dictated by availability of the
transgenic strains and litter sizes, allowing littermate controls. Pre-established exclusion criteria are based on IACUC guidelines. The
investigator was not blinded to the mouse group allocation. Tested samples were blindly assayed.
DATA AND CODE AVAILABILITY
All RNA-sequencing and micro-array data have been deposited in the Gene Expression Omnibus public database under accession
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